Age of onset in Huntington disease: Sex specific influence of apolipoprotein E genotype and normal CAG repeat length

Journal of Medical Genetics

Volumn 36, Issue 2, 1999, Pages 108-111

  Kehoe, Patrick ^a   Krawczak, Michael ^a   Harper, Peter S ^a   Owen, Michael J ^a   Jones, A Lesley ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Age of onset; APOE; Huntington disease

Indexed keywords

APOLIPOPROTEIN E; HUNTINGTIN;

ALZHEIMER DISEASE; ARTICLE; CORRELATION FUNCTION; DISEASE COURSE; FEMALE; GENOTYPE; HUMAN; HUNTINGTON CHOREA; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; SEX DIFFERENCE; TRINUCLEOTIDE REPEAT;

AGE OF ONSET; ANTICIPATION, GENETIC; APOLIPOPROTEINS E; FEMALE; GENOTYPE; HUMANS; HUNTINGTON DISEASE; MALE; MODELS, STATISTICAL; SEX FACTORS; SURVIVAL; TRINUCLEOTIDE REPEATS; VARIATION (GENETICS);

EID: 0033033679     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Huntingdon's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993;72:971-83.
2. Rubinsztein DC, Leggo J, Coles R, et al. Phenotypic characterisation of individuals with 30-40 CAG repeats in the Huntington's disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats. Am J Hum Genet 1996;58:16-22.
3. Harper PS. Huntington's disease. 2nd ed. London: Saunders, 1996.
4. Snell RG, MacMillan JC, Cheadle JP, et al. Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease. Nat Genet 1993;4:393-7.
5. Duyao M, Ambrose C, Myers R, et al. Trinucleotide repeat length instability and age of onset in Huntington's disease. Nat Genet 1993;4:387-92.
6. Andrew SE, Goldberg VP, Kremer B, et al. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nat Genet 1993;4:398-403.
7. Fairer LA, Cupples LA, Wiater P, Conneally PM, Gusella JF, Myers RH. The normal Huntington disease (HD) allele or a closely associated linked gene influences age at onset of HD. Am J Hum Genet 1993;53:125-30.
8. James CM, Houlihan GD, Snell RG, Cheadle JP, Harper PS. Late-onset Huntington's disease: a clinical and molecular study. Age Ageing 1994;23:445-8.
9. Strittmatter WJ, Saunders AM, Schmechel D. Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993;90:1977-81.
10. Evans KG, Berger EP, Cho CG, Weisgraber KH, Lansbury PT. Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer's disease. Proc Natl Acad Sci USA 1995;92:763-7.
11. Ma J, Yee A, Brewer HB, Das S, Potter H. Amyloid- associated proteins α1-antichymotrypsin and apolipoprotein E assembly of Alzheimer β-protein into filaments. Nature 1996;372:92-4.
12. Al-Chaalabi A, Enayat ZE, Bakker MC, et al. Association of apolipoprotein E σ4 allele with bulbar-onset motor neuron disease. Lancet 1996;347:159-60.
13. Miyata M, Smith JD. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and β-amyloid peptides. Nat Genet 1996;14:55-61.
14. Corder EH, Saunders AM, Strittmater WJ, et al Gene dose of apolipoprotein-E type-4 allele and the risk of Alzheimer's disease in late-onset families. Science 1993;261: 921-3.
15. Schneider JA, Gearing M, Robbins RS, de l'Aune W, Mirra SS. Apolipoprotein E genotype in diverse neurodegenerative0 disorders. Ann Neurol 1995;38:131-5.
16. Wenham PR, Price WH, Blundell G. Apolipoprotein E genotyping by one-stage PCR. Lancet 1991;337:1158-9.
17. Spiegel MR. Theory and problems of probability and statistics. New York: McGraw-Hill, 1975:268.
18. Krawczak M, Bockel B, Sandkuijl L, Thies U, Fenton I, Harper PS. Covariate dependent age of onset distributions for Huntington's disease. Am J Hum Genet 1991;49:735-45.
19. Stevanin, G, Cancel G, Didierjean O, et al. The clinical and molecular spectrum of spinocerebellar ataxia 3 and Machado-Joseph disease. Eur J Hum Genet 1996;4S1:120.
20. Mangiarini L, Sathasivam K, Seller M, et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 1996;87:493-506.
21. Nasir J, Goldberg YP, Hayden MR. Huntington disease: new insights into the relationship between CAG expansion and disease. Hum Mol Genet 1996;5:1431-5.
22. Davies SW, Turmaine M, Cozens BA, et al. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 1997;90:537-48.
23. DiFiglia M, Sapp E, Chase KO, et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 1997;277:1990-3.
24. Li XJ, Li SH, Sharp AH, et al. A huntingtin-associated protein enriched in brain with implications for pathology. Nature 1995;378:398-402.
25. Burke JR, Enghild JJ, Martin ME, et al Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH. Nat Med 1996;2:347-50.
26. Nicholl JAR, Roberts GW, Graham DI. Apolipoprotein E e4 allele is associated with deposition of amyloid β-protein following head injury. Nat Med 1995;2:135-7.
27. Payami H, Zareparsi S, Montee KR, et al. Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women. Am J Hum Genet 1996;58:803-11.